Revolutionizing organ preservation
Vivalyx develops a fully synthetic, blood-free organ preservation and revitalization solution that makes machine perfusion scalable, affordable and logistically simple. In doing so, it addresses a major global bottleneck; up to 80% of donor organs are discarded due to preservation limits that are accompanied with high costs. Current machine perfusion methods rely on human or bovine blood as an oxygen carrier which makes them logistically complex, expensive and ethically challenging. Vivalyx eliminates these hurdles while achieving equal or superior preservation outcomes.
Why we’re investing in Vivalyx
Vivalyx offers a uniquely scalable, synthetic solution to one of healthcare’s largest unmet needs — expanding the pool of transplantable organs while drastically reducing cost and complexity. Given its strong IP, proven preclinical efficacy, clear regulatory path and well-suited team, we believe Vivalyx will create high impact.